U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07664891) titled 'Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma' on March 30.
Brief Summary: The present project aims to elucidate the metabolic interactions within the tumor microenvironment of pancreatic adenocarcinoma, both in the primary tumor and in hepatic and pulmonary metastatic sites, as well as in circulating blood biomarkers.
Deciphering these complex interactions aims to identify exploitable vulnerabilities for predicting treatment efficacy or for guiding therapeutic strategies.
Study Start Date: Sept. 11, 2025
Study Type: OBSERVATIONAL
Condition:
Pancreatic Adenocarcinoma Metastatic
Intervention:
OTHER:...